After several months of chemo and immunotherapy, the 44-year-old decided the traditional treatments he’d been undergoing weren’t enough.
The crippling side effects of the drugs had left him feeling hollow—and only exacerbated his already acute feelings of anxiety and depression.
Desperate to alleviate his crushing stress, this letdown led Dan toward the decision to experiment with psilocybin.
Reading Michael Pollan’s book, How To Change Your Mind, and the research being done at Johns Hopkins gave me motivation.”.
For more than 15 years, the Johns Hopkins Psychedelic Research Unit has been the foremost research team in the US for psychedelic studies.
Key among the topics being explored were psilocybin’s effects on addiction, depression in the physically healthy, and the depression and anxiety brought on by a cancer diagnosis.
“Cancer patients show dramatic reductions of depression and anxiety that have lasted at least six months and sometimes a year—which is amazing,” he says. »
